GleamWall
中文EN

XTNT Xtant Medical Holdings, Inc.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1453593 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-24.4%
TTM net income YoY-1,014.2%
TTM EPS YoY-1,200.0%
Revenue 3-yr CAGR8.6%
Net income 3-yr CAGR—

Margins

Gross margin56.4%
Operating margin-16.0%
Net margin-15.9%
FCF margin-6.1%
EBITDA margin-12.6%

Returns

ROE-36.5%
ROA-17.6%
ROIC (approx.)-26.2%
Asset turnover1.11x

Leverage & solvency

Liabilities / assets50.5%
Debt / equity0.27x
Current ratio2.00x
Interest coverage-6.56x

Cash quality & payout

Operating cash flow / net income0.31x
Accruals ratio-12.2%
Payout ratio—
Capex / revenue1.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$133.93M$117.27M
Cost of revenue$49.65M$49.05M
Gross profit$84.27M$68.22M
R&D expense$2.10M$2.38M
SG&A expense$29.38M$28.69M
Operating income$7.28M-$12.07M
Interest expense$3.67M$4.16M
Pretax income$7.00M-$16.26M
Income tax$2.03M$187,000
Net income$4.97M-$16.45M
EBITDA$12.51M-$7.85M
EPS (basic)0.04-0.12
EPS (diluted)0.03-0.12
Weighted avg. shares (diluted)150.04M133.67M
Balance sheet
Cash & equivalents$17.05M$6.20M
Receivables$17.80M$20.66M
Inventory$30.26M$38.63M
Current assets$78.25M$67.12M
PP&E, net$6.20M$10.13M
Goodwill$6.07M$7.30M
Intangibles$299,000$8.36M
Total assets$94.14M$93.84M
Current liabilities$29.48M$28.58M
Short-term debt$3.50M—
Long-term debt$11.03M$22.04M
Total debt$14.53M$22.04M
Total liabilities$43.19M$50.87M
Shareholders' equity$50.95M$42.96M
Net debt-$2.53M$15.84M
Shares outstanding140.04M139.05M
Cash flow statement
Operating cash flow$12.55M-$11.90M
Capital expenditure$2.38M$4.11M
Free cash flow$10.16M-$16.01M
Investing cash flow$7.90M-$3.73M
Financing cash flow-$9.57M$16.07M
Depreciation & amortization$5.22M$4.22M
Stock-based compensation$2.89M$4.12M

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.